Evonetix Establishes Scientific Advisory Board
Evonetix, the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, today announced it has appointed Stephanie Brooking as Head of Product Management. Evonetix aims to utilise its innovative silicon chip approach to deliver a high-throughput solution for the synthesis and assembly of DNA molecules with high fidelity. Stephanie will help to define the Company’s strategy for market entry and longer-term product marketing for its novel gene synthesis products.
Stephanie has over 20 years’ commercial experience in the life science industry, having worked in operational, sales and marketing leadership roles to support product development and introduction, commercial launch planning and marketing content strategy. She has helped execute programmes to open new geographies and market opportunities within research, clinical, agricultural, pharmaceutical and biotechnology sectors. Previously she was the VP of Marketing and Sales at Cambridge Epigenetix, Global Commercial Director at Oxford Nanopore Technologies, and also held senior positions at Illumina, Applied Biosystems, Affymetrix and GE Healthcare (Amersham Pharmacia Biotech). She first began her career working on the Human Genome Project at the Wellcome Trust Sanger Institute.